The 8 most recent market catalysts affecting $MMSI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 55
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94
Canaccord Genuity's analyst Jon Young has maintained a 'Buy' rating on Merit Medical Systems (MMSI) and raised the price target from $85 to $94. This indicates a strengthened posit…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $95
JP Morgan analyst Robbie Marcus maintained an 'Overweight' rating on Merit Medical Systems (MMSI) and significantly raised the price target from $77 to $95. This upward revision in…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $106
Piper Sandler analyst Jason Bednar has maintained an 'Overweight' rating on Merit Medical Systems (MMSI) and raised the price target from $96 to $106. This action signals increased…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $83
Wells Fargo analyst Larry Biegelsen updated his coverage on Merit Medical Systems, raising the price target from $74 to $83 while maintaining an 'Equal-Weight' rating. This action …
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 92
Merit Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance. Also, Needham and BTIG raised their respective price targets on the stock.
This headline indicates a strong positive corporate catalyst for Merit Medical Systems. Better-than-expected earnings and raised guidance signal robust operational performance and …
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 92
These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results
Merit Medical Systems (MMSI) delivered a significant positive surprise in its Q2 earnings, beating analyst estimates on both the top and bottom lines. This strong performance, driv…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $101
Needham analyst Mike Matson maintained a 'Buy' rating on Merit Medical Systems (MMSI) and raised the price target from $90 to $101. This action signals an analyst's increased convi…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
BTIG Maintains Buy on Merit Medical Systems, Raises Price Target to $105
BTIG analyst Sam Eiber maintained a 'Buy' rating on Merit Medical Systems (MMSI) and raised the price target from $100 to $105. This action signals a positive outlook from a reputa…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.